ACTIVE

V-Bio Fund 2

Financial year 2025 · closed on 31/12/2025
Net result
-2,2 M €
-2.9% YoY
Gross margin
-2,1 M €
-0.7% YoY
Equity
51,8 M €
+87.1% YoY

What does V-Bio Fund 2 do?

V-Bio Fund 2 is a Public limited company incorporated in 2020. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0759.685.291
Incorporation
11/12/2020
Legal form
Public limited company
Registered office
Pieter van Reysschootlaan 2 box 104
9051 Gent · FlandreSee on map
Contributed capital
64 501 460,00 €
Latest accounts
31/12/2025
Contacts
2 public details availableLog in to view
Signals
Solid equity
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin-2,1 M €-2,1 M €-2,1 M €-2,5 M €-1,9 M €
EBITDA-2,1 M €-2,1 M €-2,1 M €-2,5 M €-1,9 M €
Operating result-2,2 M €-2,2 M €-2,2 M €-2,5 M €-1,9 M €
Net result-2,2 M €-2,2 M €-3,9 M €-2,5 M €-1,9 M €
Balance sheet
Equity51,8 M €27,7 M €19,2 M €13,1 M €5,6 M €
Total assets51,8 M €28,2 M €19,2 M €13,1 M €5,6 M €
Cash2,7 M €147,0 k €2,3 M €1,4 M €1,2 M €
Debts532,4 k €11,8 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

V-Bio Management 2

Mandate · 0758.543.760

Represented by Christina Takke

Active

Ended mandates

V-Bio Management 2

Director · since 11 décembre 2020 · until 10 décembre 2032 · 0758.543.760

Represented by Christina Takke

Ended
At this address

Other companies at this address

CompanyCBE no.
0886.996.605
CD-VastgoedActive
0465.063.827
HONEY COMPANYActive
0793.625.294
1002.228.546
0712.738.182
V-Bio Fund 1Active
0642.766.540
0641.986.877
0758.543.760
0641.850.186
0758.543.661
V-Bio VenturesActive
0758.544.057
0839.676.936
Annual accounts

Full financial information

20252024202320222021
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202211/12/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months13 months
Filing date18/06/202602/06/202526/06/202423/06/202329/12/2022
General meeting26/05/202627/05/202528/05/202430/05/202331/05/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/05/202618/06/2026DutchPDF
Abridged model31/12/202427/05/202502/06/2025DutchPDF
Micro model31/12/202328/05/202426/06/2024DutchPDF
Micro model31/12/202230/05/202323/06/2023DutchPDF
Micro model31/12/202131/05/202229/12/2022DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

V-Bio Management 2

Mandate · 0758.543.760

Represented by Christina Takke

Active

Ended mandates

V-Bio Management 2

Director · since 11 décembre 2020 · until 10 décembre 2032 · 0758.543.760

Represented by Christina Takke

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares20/04/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares15/04/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares13/11/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares28/03/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares28/01/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares15/10/2021
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares10/02/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares18/12/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 08/04/2026
    augmentation_capital
  2. 2025
    Annual accounts 2025-2,2 M €
  3. 10/04/2025
    augmentation_capital
  4. 2024
    Annual accounts 2024-2,2 M €
  5. 2023
    Annual accounts 2023-3,9 M €
  6. 31/10/2023
    augmentation_capital
  7. 2022
    Annual accounts 2022-2,5 M €
  8. 2022
    Name changeV-Bio Fund 2 Private Privak
  9. 2021
    Annual accounts 2021-1,9 M €
  10. 2021
    Name changeV-Bio Fund 2 NV
  11. 11/12/2020
    IncorporationPublic limited company